Alterity Therapeutics (ATHE) Prepaid Assets (2009 - 2025)
Alterity Therapeutics (ATHE) recorded quarterly Prepaid Assets of $512117.8 in Q4 2025, down 90.89% quarter-over-quarter from $5.6 million in Q2 2025, and up 271.99% on a YoY basis from $137668.3 in Q4 2024.
Alterity Therapeutics (ATHE) Prepaid Assets (2009 - 2025) Analysis & Trends
Alterity Therapeutics' Prepaid Assets history runs 16 years deep, the most recent figure standing at $512117.8 for Q4 2025.
- In Q4 2025, Prepaid Assets rose 271.99% year-over-year to $512117.8; the TTM figure through Dec 2025 stood at $512117.8 (up 271.99% YoY), while the FY2025 annual figure was $5.6 million, up 23749.94% from the prior year.
- Prepaid Assets was $512117.8 for Q4 2025 at Alterity Therapeutics, down from $5.6 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $5.6 million in Q2 2025 to a low of $137668.3 in Q4 2024.
- Historically, Prepaid Assets has averaged $1.6 million across 5 years, with a median of $1.2 million in 2022.
- The sharpest annual moves came in 2023 and 2024: Prepaid Assets surged 361.03% in 2023, then sank 94.27% in 2024.
- A 5-year view of Prepaid Assets shows it stood at $1.2 million in 2021, then sank by 55.32% to $520809.4 in 2022, then surged by 361.03% to $2.4 million in 2023, then tumbled by 94.27% to $137668.3 in 2024, then surged by 271.99% to $512117.8 in 2025.
- The last three Prepaid Assets figures came in at $512117.8 (Q4 2025), $5.6 million (Q2 2025), and $137668.3 (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 512,117.76 |
| Jun 30, 2025 | 5.62 Mn |
| Dec 31, 2024 | 137,668.33 |
| Jun 30, 2024 | 1.53 Mn |
| Dec 31, 2023 | 2.40 Mn |
| Jun 30, 2023 | 1.74 Mn |
| Dec 31, 2022 | 520,809.36 |
| Jun 30, 2022 | 1.15 Mn |
| Dec 31, 2021 | 1.17 Mn |
| Jun 30, 2021 | 843,790.23 |
| Dec 31, 2020 | 254,870.38 |
| Jun 30, 2020 | 378,922.26 |
| Dec 31, 2019 | 211,606.15 |
| Jun 30, 2019 | 435,509.53 |
| Dec 31, 2018 | 80.85 |
| Jun 30, 2018 | 201,844.97 |
| Dec 31, 2017 | 300,146.52 |
| Jun 30, 2017 | 247.60 |
| Dec 31, 2016 | 107,128.62 |
| Jun 30, 2016 | 206.46 |